Repligen Corp [RGEN] stock prices are up 3.22% to $134.0 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The RGEN shares have gain 5.55% over the last week, with a monthly amount glided 1.76%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Repligen Corp [NASDAQ: RGEN] stock has seen the most recent analyst activity on June 24, 2025, when Barclays initiated its Overweight rating and assigned the stock a price target of $150. Previously, Wolfe Research upgraded its rating to Outperform on April 29, 2025, and kept the price target unchanged to $160. On March 18, 2025, Evercore ISI initiated with a In-line rating and assigned a price target of $155 on the stock. TD Cowen started tracking the stock assigning a Buy rating and suggested a price target of $200 on February 10, 2025. Canaccord Genuity initiated its recommendation with a Hold and recommended $165 as its price target on December 17, 2024. In a note dated August 28, 2024, Wells Fargo initiated an Overweight rating and provided a target price of $180 on this stock.
The stock price of Repligen Corp [RGEN] has been fluctuating between $102.96 and $182.52 over the past year. Currently, Wall Street analysts expect the stock to reach $193.86 within the next 12 months. Repligen Corp [NASDAQ: RGEN] shares were valued at $134.0 at the most recent close of the market. An investor can expect a potential return of 44.67% based on the average RGEN price forecast.
Analyzing the RGEN fundamentals
The Repligen Corp [NASDAQ:RGEN] reported sales of 650.43M for trailing twelve months, representing a surge of 10.44%. Gross Profit Margin for this corporation currently stands at 0.43% with Operating Profit Margin at -0.06%, Pretax Profit Margin comes in at -0.04%, and Net Profit Margin reading is -0.04%. To continue investigating profitability, this company’s Return on Assets is posted at -0.01, Equity is -0.01 and Total Capital is -0.01. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.34.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 130.43 points at the first support level, and at 126.85 for the second support level. However, for the 1st resistance point, the stock is sitting at 136.30, and for the 2nd resistance point, it is at 138.59.
Ratios To Look Out For
It’s worth pointing out that Repligen Corp [NASDAQ:RGEN]’s Current Ratio is 6.79. As well, the Quick Ratio is 5.79, while the Cash Ratio is 4.59. Considering the valuation of this stock, the price to sales ratio is 11.57, the price to book ratio is 3.79.
Transactions by insiders
Recent insider trading involved Hunt Anthony, Director, that happened on May 15 ’25 when 26447.0 shares were sold. Director, Hunt Anthony completed a deal on May 15 ’25 to buy 26447.0 shares. Meanwhile, Director Hunt Anthony sold 26756.0 shares on Mar 17 ’25.
